A Site-Specific Integrated Col2.3GFP Reporter Identifies Osteoblasts Within Mineralized Tissue Formed In Vivo by Human Embryonic Stem Cells. (13th August 2014)

• Record Type: Journal Article
• Authors: Xin, Xiaonan; Jiang, Xi; Wang, Liping; Stover, Mary Louise; Zhan, Shuning; Huang, Jianping; Goldberg, A. Jon; Liu, Yongxing; Kuhn, Liisa; Reichenberger, Ernst J.; Rowe, David W.; Lichtler, Alexander C.
• Is Part Of: Stem cells translational medicine. Volume 3:Number 10(2014)
• Page Start: 1125
• Page End: 1137
• Publication Date: 2014-08-13
• Subjects: Zinc fingers -- Gene targeting -- Mesenchymal stem cell -- Osteoblast -- Bone; Stem cells -- Periodicals; Regenerative medicine -- Periodicals; Periodicals; 616.0277405
• DOI: 10.5966/sctm.2013-0128
• Languages: English
• ISSNs: 2157-6564

Abstract

Abstract: The use of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) for study and treatment of bone diseases or traumatic bone injuries requires efficient protocols to differentiate hESCs/iPSCs into cells with osteogenic potential and the ability to isolate differentiated osteoblasts for analysis. We have used zinc finger nuclease technology to deliver a construct containing the Col2.3 promoter driving GFPemerald to the AAVS1 site (referred to as a "safe harbor" site), in human embryonic stem cells (H9Zn2.3GFP), with the goal of marking the cells that have become differentiated osteoblasts. In teratomas formed using these cells, we identified green fluorescent protein (GFP)-positive cells specifically associated with in vivo bone formation. We also differentiated the cells into a mesenchymal stem cell population with osteogenic potential and implanted them into a mouse calvarial defect model. We observed GFP-positive cells associated with alizarin complexone-labeled newly formed bone surfaces. The cells were alkaline phosphatase-positive, and immunohistochemistry with human specific bone sialoprotein (BSP) antibody indicates that the GFP-positive cells are also associated with the human BSP-containing matrix, demonstrating that the Col2.3GFP construct marks cells in the osteoblast lineage. Single-cell cloning generated a 100% Col2.3GFP-positive cell population, as demonstrated by fluorescence in situ hybridization using a GFP probe. The karyotype was normal, and pluripotency was demonstrated by Tra1-60 immunostaining, pluripotent low density reverse transcription-polymerase chain reaction array and embryoid body formation. These cells will be useful to develop optimal osteogenic differentiation protocols and to isolate osteoblasts from normal and diseased iPSCs for analysis. Abstract : A combination of reagents and methodologies was developed that enables the rapid, definitive assessment of human bone formation in a mouse bone defect repair model, and a method was developed for inserting the Col2.3GFP reporter construct into a specific location in the human genome. Results indicate that this inserted Col2.3GFP construct provides a marker for differentiation of human embryonic stem cells, which will allow objective evaluation of preimplantation differentiation protocols for in vivo human bone formation.